CD30BNIP3线EBVB线

Wei-Ting Wang1, Tong-Yao Xing1, Kai-Xin Du1

  • 1Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, China; Key Laboratory of Hematology of Nanjing Medical University, Nanjing 210029, China; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing 210029, China.

Cancer letters
|January 11, 2024
PubMed
概括

CD30阳性表明爱斯坦-巴尔病毒阳性扩散大B细胞淋巴瘤 (EBV+DLBCL) 的预后不佳. CD30 缺乏症通过 BNIP3 破坏线粒细胞吸收,从而影响 EBV+ DLBCL 的生长,这表明抗 CD30 治疗的潜力.